NTLA - Intellia Therapeutics Inc
$147.58-1.56(-1.05%)8:00:00 PM 9/27/2021
Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and Virginijus Šikšnys . The company has partnerships with Novartis and Regeneron. Intellia Therapeutics was founded in May 2014 to develop biopharmaceuticals using CRISPR.
Stock Chart
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
No summary
Related Topics
leak data
Peers
Stock news
09/3/2021NTLA
08/31/2021NTLA
08/5/2021NTLA
08/5/2021NTLA
08/4/2021NTLA
07/12/2021NTLA